SCHEMBL16414446

SCHEMBL16414446

CC(=O)c1ccncc1I

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 6/20 0.44
▸ KDM6B O15054 4/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KDM4D Q6B0I6 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KDM4A O75164 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ GLA P06280 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ SIRT3 Q9NTG7 1/20 0.42
▸ HASPIN Q8TF76 1/20 0.41
▸ GSK3B P49841 1/20 0.39
▸ CSNK1A1 P48729 1/20 0.38
▸ CSNK1D P48730 1/20 0.38
▸ CLK2 P49760 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5700319 0.85 TDP1 (0.46) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL28317597 0.82 TDP1 (0.50) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL5700390 0.81 MAPT (0.39) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL1023235 0.80 KDM4C (0.61) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL5700307 0.78 TDP1 (0.57) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL1798009 0.78 P2RX1 (0.47) KDM4CKDM6BKDM4EALDH1A1TDP1
Hydrochloric Acid SCHEMBL4259779 0.78 KDM4C (0.59) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL1885868 0.78 TDP1 (0.52) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL6869843 0.78 KDM4C (0.49) KDM4CKDM6BKDM4EALDH1A1TDP1
SCHEMBL1025153 0.78 KDM4E (0.66) KDM4CKDM6BKDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2865446-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL KANTO KAGAKU (JP) 2021-09-22 — — EP disclosed
US-9174906-B2 Process for producing optically active secondary alcohol KANTO KAGAKU KABUSHIKI KAISHA (JP) 2015-11-03 — — US disclosed
EP-2865446-A1 Process for producing optically active secondary alcohol Kanto Kagaku Kabushiki Kaisha (JP) 2015-04-29 — — EP disclosed
US-20150031920-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2015-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031920-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL ADH1A, ADH1C, ADH5 KDM4C 785/4885KDM6B 657/4885KDM4E 1802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback